Aminoleban EN
PreclinicalSmall molecule
Aminoleban EN is one of 7 small molecule programs targeting Quality of Life. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
6
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
7 competitors in Quality of Life
#DrugCompanyPhaseTrials
1Tryptyr
FFalcon
Approved
Pilocarpine Hcl
AbbViePhase 3
R-Gene 10
PPharmacia and Upjohn
Preclinical
Opioids
SSahlgrenska University Hospital
Preclinical
Sustanon 250
UUniversity of Nottingham
Phase 1
Medications
YYale University
Preclinical
Aminoleban EN
KKochi University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Aminoleban EN. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- KKochi University